Is Collegium Pharmaceutical Inc (COLL) Stock a Bad Value Thursday?

Collegium Pharmaceutical Inc (COLL) is near the top in its sector according to InvestorsObserver. COLL gets an overall rating of 82. That means it scores higher than 82% of stocks. Collegium Pharmaceutical Inc gets a 90 rank in the Healthcare sector. Healthcare is number 4 out of 11 sectors.

COLL has an Overall Score of 82. Find out what this means to you and get the rest of the rankings on COLL!

See Full COLL Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Collegium Pharmaceutical Inc Stock Today?

Collegium Pharmaceutical Inc (COLL) stock has gained 0.46% while the S&P 500 is down -0.13% as of 1:25 PM on Thursday, Nov 16. COLL is up $0.12 from the previous closing price of $24.96 on volume of 80,213 shares. Over the past year the S&P 500 has risen 13.59% while COLL is up 19.54%. COLL earned $0.07 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 348.26. Click Here to get the full Stock Report for Collegium Pharmaceutical Inc stock.